SERPINE1 and chronic thromboembolic pulmonary hypertension: In a study by Vuylsteke et al. [80] tissue plasminogenactivators (t-PA) and plasminogen activator inhibitor-1 (PAI-1) weresignificantly higher in CTEPH patients.